600750 Stock Overview
Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Jiang Zhong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥20.62 |
| 52 Week High | CN¥28.58 |
| 52 Week Low | CN¥18.17 |
| Beta | 0.32 |
| 11 Month Change | -7.41% |
| 3 Month Change | -0.43% |
| 1 Year Change | -5.37% |
| 33 Year Change | 67.51% |
| 5 Year Change | 109.69% |
| Change since IPO | 99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600750 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.8% | -0.6% | -2.8% |
| 1Y | -5.4% | -8.7% | 2.0% |
Return vs Industry: 600750 exceeded the CN Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 600750 underperformed the CN Market which returned 2% over the past year.
Price Volatility
| 600750 volatility | |
|---|---|
| 600750 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600750 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600750's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 4,013 | Wenbin Xiao | www.jzjt.com |
Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and prescription products.
Jiang Zhong Pharmaceutical Co.,Ltd Fundamentals Summary
| 600750 fundamental statistics | |
|---|---|
| Market cap | CN¥12.84b |
| Earnings (TTM) | CN¥750.31m |
| Revenue (TTM) | CN¥4.13b |
17.1x
P/E Ratio3.1x
P/S RatioIs 600750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600750 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.13b |
| Cost of Revenue | CN¥1.41b |
| Gross Profit | CN¥2.71b |
| Other Expenses | CN¥1.96b |
| Earnings | CN¥750.31m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 65.81% |
| Net Profit Margin | 18.19% |
| Debt/Equity Ratio | 0% |
How did 600750 perform over the long term?
See historical performance and comparison